Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
Human African trypanosomiasis (HAT or ‘sleeping sickness’) is a neglected tropical disease. If untreated, it is always fatal and leads to death. A few treatments are available for HAT, but most of them require a skilled professional, which increases the financial burden on the patient. Recently, fex...
Main Authors: | Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Ashwaq Muiedh Alqahtani, Turkiah Abdullah Alanazi, Mehnaz Kamal, Talha Jawaid, Mohammed M. Ghoneim, Sultan Alshehri, Faiyaz Shakeel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/2/128 |
Similar Items
-
Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole
by: Philippe Neau, et al.
Published: (2020-01-01) -
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
by: Emily A. Dickie, et al.
Published: (2020-02-01) -
Centering Patient Expectations of a Novel Home-Based Oral Drug Treatment among <i>T. b. rhodesiense</i> Human African Trypanosomiasis Patients in Uganda
by: Shona J Lee, et al.
Published: (2020-01-01) -
A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against <i>Helicobacter pylori</i>
by: Abdolhakim Mohamed, et al.
Published: (2022-11-01) -
Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
by: Sonja Bernhard, et al.
Published: (2022-10-01)